✦ LIBER ✦

Changing concepts in multiple myeloma: from conventional chemotherapy to high-dose treatment

✍ Scribed by P. Sonneveld; C.M. Segeren

Book ID: 117659161
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 171 KB
Volume: 39
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(02)00503-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Single-agent thalidomide for treatment o

Single-agent thalidomide for treatment of first relapse following high-dose chemotherapy in patients with multiple myeloma

✍ Fenk, R; Hoyer, B; Steidl, U; Kondakci, M; Graef, T; Heuk, R; Ruf, L; Strupp, C; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 118 KB

Maintenance Treatment with Recombinant I

Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction Chemotherapy

✍ Mandelli, Franco; Avvisati, Giuseppe; Amadori, Sergio; Boccadoro, Mario; Gernone 📂 Article 📅 1990 🏛 Massachusetts Medical Society 🌐 English ⚖ 886 KB

In vitro studies of ways to overcome res

In vitro studies of ways to overcome resistance to VAMP-high dose melphalan in the treatment of multiple myeloma

✍ B. C. Millar; J. B. G. Bell; J. A. Maitland; A. Zuiable; M. E. Gore; P. J. Selby 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 860 KB

Response to induction chemotherapy is no

Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myeloma

✍ Singhal, S; Powles, R; Sirohi, B; Treleaven, J; Kulkarni, S; Mehta, J 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 116 KB

High doses of natural α-interferon (α-IF

High doses of natural α-interferon (α-IFN) in the treatment of multiple myeloma — A pilot study from the Myeloma Group of Central Sweden (MGCS)

✍ A. Åhre; M. Björkholm; A. Österborg; G. Brenning; G. Gahrton; H. Gyllenhammar; G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB

186: Bortezomib Added to High-Dose Cyclo

186: Bortezomib Added to High-Dose Cyclophosphamide During Stem Cell Mobilization is Safe and Provides Effective Disease Control in Chemotherapy-Refractory Multiple Myeloma

✍ M. Voralia; C. Fibich; M. Katzman; P. Danyluk; T. George; H. Doell; A. Evjen; J. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 77 KB